Vandenberghe, R., Rinne, J. O., Boada, M., Katayama, S., Scheltens, P., Vellas, B., . . . Black, R. S. (2016). Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials. Alzheimers Res Ther.
استشهاد بنمط شيكاغوVandenberghe, Rik, et al. "Bapineuzumab for Mild to Moderate Alzheimer’s Disease in Two Global, Randomized, Phase 3 Trials." Alzheimers Res Ther 2016.
MLA استشهادVandenberghe, Rik, et al. "Bapineuzumab for Mild to Moderate Alzheimer’s Disease in Two Global, Randomized, Phase 3 Trials." Alzheimers Res Ther 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.